Key result
Daily peripheral focused ultrasound stimulation of the hepatoportal neural plexus significantly reduced circulating glucose levels and improved insulin resistance in multiple animal models of type 2 diabetes.
Why the study?
The importance of peripheral glucose sensor pathways in maintaining energy homeostasis and their contribution to disease remain unknown.
Does transient peripheral focused ultrasound (pFUS) of the hepatoportal neural plexus improve glucose homeostasis in models of insulin resistant diabetes?
Does transient peripheral focused ultrasound (pFUS) of the hepatoportal neural plexus improve glucose homeostasis in models of insulin resistant diabetes?
p-value: p=<0.01
Peripheral focused ultrasound targeting the hepatic neural plexus represents a potential novel, non-pharmacologic therapeutic modality to restore glucose homeostasis in metabolic diseases such as type II diabetes.
Noninvasive neural modulation may improve glycemic control in insulin resistance; leaves open translation to human disease.
While peripheral glucose sensors are known to relay signals of substrate availability to integrative nuclei in the brain, the importance of these pathways in maintaining energy homeostasis and their contribution to disease remain unknown. Herein, we demonstrate that selective activation of the hepatoportal neural plexus via transient peripheral focused ultrasound (pFUS) induces glucose homeostasis in models of well-established insulin resistant diabetes. pFUS modulates sensory projections to the hindbrain and alters hypothalamic concentrations of neurotransmitters that regulate metabolism, resulting in potentiation of hypothalamic insulin signaling, leptin-independent inhibition of the orexigenic neuropeptide Y system, and therapeutic alteration in autonomic output to peripheral effector organs. Multiomic profiling confirms pFUS-induced modifications of key metabolic functions in liver, pancreas, muscle, adipose, kidney, and intestines. Activation of the hepatic nutrient sensing pathway not only restores nervous system coordination of peripheral metabolism in three different species but does so across these organ systems; several of which are current targets of antidiabetic drug classes. These results demonstrate the potential of hepatic pFUS as a novel/non-pharmacologic therapeutic modality to restore glucose homeostasis in metabolic diseases, including type II diabetes. One Sentence Summary We utilize a non-invasive ultrasound technique to activate a liver-brain sensory pathway and demonstrate its potential to induce durable normalization of glucose homeostasis in models of well-established insulin resistant diabetes.
No takes yet. Share an insight, caveat, or question.
Cotero et al. (2021) studied Type 2 Diabetes. Peripheral focused ultrasound (pFUS) of the hepatic neural plexus vs. Sham treatment was evaluated on Plasma glucose levels (Area Under the Curve during Glucose Tolerance Tests) and HOMA-IR (p=<0.01). Daily peripheral focused ultrasound stimulation of the hepatoportal neural plexus significantly reduced circulating glucose levels and improved insulin resistance in multiple animal models of type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: